Is Kinesio Taping Treatment Effective in Children With Cerebral Palsy?
NCT ID: NCT03819205
Last Updated: 2019-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
34 participants
INTERVENTIONAL
2018-04-15
2019-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The impaired upper limb function of children with cerebral palsy (CP) limits and restricts participation in activities of daily living.
Kinesio Taping (KT) is commonly used in sport injuries, in neurology and oncology patients following the surgical protocols, and for pediatric rehabilitation to reduce pain, facilitate or inhibit muscle activity, prevent injuries, reposition joints, aid the lymphatic system, support postural alignment, and improve proprioception. Kinesiotaping is a treatment that has not been studied much and can be applied in cerebral palsy. The tapes were grouped as elastic and rigid. In fact, there has been a few studies that investigates the effect of upper extremity elastic kinesiotaping. High methodological studies about its efficacy in this population are rare.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Kinesio Taping in Cerebral Palsy Upper Extremity Functionality
NCT04529486
The Effects of Vibration and Kinesiology Tape Applications in Children With Hemiplegic Cerebral Palsy
NCT05062122
Effects Of Kinesio Taping On Balance, Functionality, And Participation In Children With Cerebral Palsy?
NCT04932538
The Effect of Kinesio Taping on q Angle and Pes Planus in Children With Cerebral Palsy
NCT06004271
The Effect of Kinesiologic Taping on Trunk Control and Balance in Children With Cerebral Palsy
NCT07188961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
kinesiotaping group(before/after)
* Hemiplegic CP:Kinesiotaping on the affected side
* Diplegic, tetraplegic CP: side of upper extremity which children have been used to but have obstacles in daily life
* intervention Duration: For 1 week at least 2-3 hours a day, renewing if it's necessary.
* Note:Patients will be also recomended dealing with the grasping and releasing activities in daily living at about 2-3 hours a day.
* Evaluation: In a way that every patient has to be the control of themselves, 1 week before kinesiotaping, immediately after kinesiotaping and 1 week after the period of kinesiotaping, patients will be evaluated with box and block test, nine hole peg test, modified house clasification and the active/passive wrist dorsiflexion range of motion
kinesiotaping
The participants will receive kinesiotaping treatment on the affected side for the hemiplegic CP's and for diplegic, tetraplegic CP's the side of upper extremity which children have been used to but have obstacles in daily life for 1 week at least 2-3 hours a day, renewing if it's necessary. The participants will be also recomended dealing with the grasping and releasing activities in daily living at about 2-3 hours a day. In a way that every patient has to be the control of themselves, 1 week before kinesiotaping, immediately after kinesiotaping and 1 week after the period of kinesiotaping, patients will be evaluated with box and block test, nine hole peg test, modified house clasification and the active/passive wrist dorsiflexion range of motion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
kinesiotaping
The participants will receive kinesiotaping treatment on the affected side for the hemiplegic CP's and for diplegic, tetraplegic CP's the side of upper extremity which children have been used to but have obstacles in daily life for 1 week at least 2-3 hours a day, renewing if it's necessary. The participants will be also recomended dealing with the grasping and releasing activities in daily living at about 2-3 hours a day. In a way that every patient has to be the control of themselves, 1 week before kinesiotaping, immediately after kinesiotaping and 1 week after the period of kinesiotaping, patients will be evaluated with box and block test, nine hole peg test, modified house clasification and the active/passive wrist dorsiflexion range of motion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Following up with diagnose of hemiplegic/diplegic/tetraplegic CP patients with current imaginig findings
3. Patient with stable clinical status
4. Stage ≤2 patients depended on the modified ascwort scale
5. Patients who are eligible to participate the study tests with suitable cognitive state
6. Patients who agreed to participate the study.
Exclusion Criteria
2. Botilinum toxin intervention to the upper extremity in the last 6 months.
3. Patients who undergo upper extremity surgery.
4. Patients who have contraindication for kinesiotaping (Wide and severe skin injury, open wounds at risk of infection , allergic reactions)
5. Patients with intense sensory and motor loss in the banding area
6. Patients classified in stage IIB and above according to Zancolli stage
6 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dokuz Eylul University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ZEYNEP TOKEL
: Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zeynep Tokel, MD
Role: PRINCIPAL_INVESTIGATOR
Dokuz Eylul University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dokuz Eylul University
Izmir, İ̇zmi̇r, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zeynep Tokel, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DorkuzEUZTOKEL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.